Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Great Southern Bancorp
GSBC
$874M
| $773K | ﹤0.01% |
12,615
-5,207
| -29% | -$317K |
|
3477
Sprott Physical Silver Trust
PSLV
$12B
| $772K | ﹤0.01% |
49,156
-180,483
| -79% | -$2.41M |
|
3478
FerroAtlántica
GSM
$594M
| $765K | ﹤0.01% |
168,191
-443,824
| -73% | -$1.9M |
|
3479
PUT
Lumen
LUMN
$6.57B
| $765K | ﹤0.01% |
125,000
| – | – |
|
|
MH
3480
McGraw Hill
MH
$2.1B
| $765K | ﹤0.01% |
+60,953
| New | +$884K |
|
3481
Genie Energy
GNE
$367M
| $764K | ﹤0.01% |
51,122
-9,183
| -15% | -$164K |
|
3482
Silvercrest Asset Management
SAMG
$79M
| $763K | ﹤0.01% |
48,473
-5,075
| -9% | -$82.8K |
|
|
PHLT
3483
DELISTED
Performant Healthcare Inc
PHLT
| $763K | ﹤0.01% |
98,734
-59,777
| -38% | -$381K |
|
|
BCAX
3484
Bicara Therapeutics
BCAX
$1.78B
| $760K | ﹤0.01% |
48,148
-9,186
| -16% | -$103K |
|
3485
CALL
CME Group
CME
$96.3B
| $757K | ﹤0.01% |
2,800
-2,800
| -50% | -$762K |
|
3486
Eagle Bancorp Montana
EBMT
$187M
| $756K | ﹤0.01% |
43,792
+16,343
| +60% | +$278K |
|
3487
Farmers National Banc Corp
FMNB
$939M
| $755K | ﹤0.01% |
52,382
-19,161
| -27% | -$275K |
|
3488
CALL
Tarsus Pharmaceuticals
TARS
$2.58B
| $755K | ﹤0.01% |
+12,700
| New | +$625K |
|
3489
Celanese
CE
$4.9B
| $754K | ﹤0.01% |
17,925
-140,242
| -89% | -$6.98M |
|
3490
Forum Energy Technologies
FET
$708M
| $752K | ﹤0.01% |
28,165
-1,918
| -6% | -$44.3K |
|
3491
Consolidated Water Co
CWCO
$467M
| $750K | ﹤0.01% |
21,262
-4,428
| -17% | -$141K |
|
3492
Banco Macro
BMA
$5.88B
| $750K | ﹤0.01% |
17,725
+8,007
| +82% | +$489K |
|
3493
MGP Ingredients
MGPI
$379M
| $750K | ﹤0.01% |
30,984
-7,152
| -19% | -$207K |
|
3494
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
| $749K | ﹤0.01% |
9,647
-100,000
| -91% | -$7.6M |
|
3495
Personalis
PSNL
$1.35B
| $749K | ﹤0.01% |
114,803
-25,575
| -18% | -$146K |
|
|
TTAM
3496
Titan America SA
TTAM
$2.85B
| $745K | ﹤0.01% |
49,898
+5,646
| +13% | +$83.3K |
|
3497
Solid Power
SLDP
$463M
| $745K | ﹤0.01% |
214,790
-32,574
| -13% | -$123K |
|
|
GAMB
3498
DELISTED
Gambling.com
GAMB
| $745K | ﹤0.01% |
91,073
+41,849
| +85% | +$405K |
|
|
NUVL
3499
CALL
DELISTED
Nuvalent
NUVL
| $744K | ﹤0.01% |
8,600
-2,200
| -20% | -$174K |
|
3500
Allogene Therapeutics
ALLO
$649M
| $743K | ﹤0.01% |
598,997
-46,328
| -7% | -$55.2K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.